NCT02960646 2023-02-16Engineered Donor Stem Cell Transplant in Treating Patients With Hematologic MalignanciesM.D. Anderson Cancer CenterPhase 1 Completed11 enrolled
NCT00691015 2017-06-28Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell TransplantBarbara Ann Karmanos Cancer InstitutePhase 2 Completed48 enrolled 12 charts
NCT00080925 2012-03-08T-Cell-Depleted Allogeneic Stem Cell Transplantation After Immunoablative Induction Chemotherapy and Reduced-Intensity Transplantation Conditioning in Treating Patients With Hematologic MalignanciesNational Institutes of Health Clinical Center (CC)Phase 1 Completed20 enrolled